Sutro Biopharma, Inc. Share Price

Sutro Biopharma, Inc. Share Price

NASDAQ: STRO | Micro Cap
$9.17
-$0.11 (-1.19%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Sutro Biopharma, Inc. Stock Performance

Open
$9.46
Prev. Close
$9.28
Circuit Range
N/A
Day Range
$9.11 - $9.71
Year Range
$0.72 - $42.38
Volume
18,157
Average Traded
$9.34

Sutro Biopharma, Inc. Share Price Today

As of 30 October 2026, Sutro Biopharma, Inc.'s share price is $9.17. The stock opened at $9.46, compared to its previous close of $9.28. During today's trading session, Sutro Biopharma, Inc.'s share price traded between $9.11 and $9.71, with an average price of $9.41. Over the past 52 weeks, the stock has recorded a high of $42.38 and a low of $0.72. In terms of performance, Sutro Biopharma, Inc.'s share price has declined by 75.04% over the last six months and is up 726.13% on a year-on-year basis.

Sutro Biopharma, Inc. Share Price Chart

Line chart of the Sutro Biopharma, Inc. price trend over the selected period. The price fell overall, ranging from 9.11 to 9.76, ending at 9.17.
$9.11$9.71
L
Show Current Price
H

Sutro Biopharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$77.92M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-10.89
Revenue (TTM)
$102.48B
Return On Equity (TTM)
174.84%
Profit Margin
-186.47%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
32.24%

Sutro Biopharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$9.69$11.65$14.52$9.84
Net Profit-$56.86-$46.76-$38.48-$38.53
Net Profit Margin-586.79%-401.37%-265.01%-391.57%
Income ChangeN/A17.76%17.71%-0.13%

Sutro Biopharma, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$67.77$153.73$62.04$102.48
Net Profit-$119.20-$106.79-$227.46-$191.09
Net Profit Margin-175.89%-69.47%-366.63%-186.47%
Income ChangeN/A10.41%-113.00%15.99%

About Sutro Biopharma, Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Sutro Biopharma, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$15.99
$9.20
-43.45%
Sep 2026
$20.29
$16.26
-24.16%
Aug 2026
$23.35
$21.44
-11.29%
Jul 2026
$32.76
$24.17
-27.30%
Jun 2026
$28.31
$33.24
+14.82%
May 2026
$37.12
$28.95
-21.18%
Apr 2026
$25.53
$36.73
+48.01%
Mar 2026
$19.69
$24.82
+20.25%
Feb 2026
$14.76
$20.64
+40.41%
Jan 2026
$11.44
$14.70
+28.22%
Dec 2025
$0.85
$11.46
+1,153.01%
Nov 2025
$1.06
$0.92
-17.57%

STRO Share Price FAQs